The gene expression market in Japan is expected to reach a projected revenue of US$ 2,369.1 million by 2030. A compound annual growth rate of 6.8% is expected of Japan gene expression market from 2023 to 2030.
Catalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp
Other key industry trends
In terms of revenue, Japan accounted for 10.1% of the global gene expression market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, Japan gene expression market is projected to lead the regional market in terms of revenue in 2030.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,890.7 million by 2030.
There is high adoption of latest technology in Japan compared to other countries in the APAC region. The country held the highest revenue share in the region in 2017. Japan is listed among countries leading in genomic, gene therapy, and cell-based research along with advancements in bioinformatics.
The country maintains its own data repositories, such as DNA Data Bank of Japan (DDBJ), and Kyoto Encyclopedia of Genes and Genomes. These provide tools, such as GenomeNet Bioinformatics Tools, for sequencing, genome, and chemical analysis.
In addition, it also has Cancer Gene Expression Database that provides gene expression profiling with clinical information of cancer tissues. In addition, Rice Expression Profile Database, a repository of gene expression profiles of microarrays, which includes the growth of rice plants, is maintained.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Gene Expression Market will help companies and investors design strategic landscapes.
Cdna Synthesis & Conversion was the largest segment with a revenue share of 26.86% in 2022.
Horizon Databook has segmented the Japan gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.
There is high adoption of latest technology in Japan compared to other countries in the APAC region. The country held the highest revenue share in the region in 2017. Japan is listed among countries leading in genomic, gene therapy, and cell-based research along with advancements in bioinformatics.
The country maintains its own data repositories, such as DNA Data Bank of Japan (DDBJ), and Kyoto Encyclopedia of Genes and Genomes. These provide tools, such as GenomeNet Bioinformatics Tools, for sequencing, genome, and chemical analysis.
In addition, it also has Cancer Gene Expression Database that provides gene expression profiling with clinical information of cancer tissues. In addition, Rice Expression Profile Database, a repository of gene expression profiles of microarrays, which includes the growth of rice plants, is maintained.
Japan Gene Expression Market Process Outlook (Revenue, USD Million , 2018-2030)
Sample Collection
Purification
cDNA Synthesis & Conversion
PCR Analysis
Data Analysis & Interpretation
Japan Gene Expression Market Product Outlook (Revenue, USD Million , 2018-2030)
Kits & Reagents
DNA Chips
Others
Japan Gene Expression Market Capacity Outlook (Revenue, USD Million , 2018-2030)
Low- to Mid- Plex
High-Plex
Japan Gene Expression Market Application Outlook (Revenue, USD Million , 2018-2030)
Drug Discovery & Development
Clinical Diagnostics
Biotech & Microbiology
Others
Japan Gene Expression Market Technique Outlook (Revenue, USD Million , 2018-2030)
RNA Expression
Promoter Analysis
Protein Expression & Posttranslational Modification Analysis
Reasons to subscribe to gene expression analysis market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of gene expression analysis market databook
Our clientele includes a mix of gene expression analysis market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan gene expression analysis market, including forecasts for subscribers. This country databook contains high-level insights into Japan gene expression analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.